Filing metadata

Accession number
0001567619-19-021770
Form type
Form 3
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Nov 18, 2019
Reporting period
Nov 12, 2019
Description
Initial ownership

Explore SEC Filings Hub